OUR EXPERTISE
- In vitro assay to identify anti-inflammatory potential using cell lines or primary cultured cells to induce phenotypes associated with various inflammatory diseases (atopic dermatitis, inflammatory bowel disease, psoriasis, asthma).
- Use of primary human cells (peripheral blood mononuclear cells (PBMC), monocytes, dendritic cells, keratinocytes, fibroblasts or reconstituted human skin)
- Animal models for the study of inflammatory bowel diseases (DSS-induced ulcerative colitis, TNBS-induced ulcerative colitis)
- Animal models for studying skin inflammation (oxazolone-induced atopic dermatitis, MC903-induced atopic dermatitis, imiquimod-induced psoriasis)
- Animal model for the study of joint inflammation (MIA-induced osteoarthritis)
- Animal models for the study of respiratory diseases (LPS-induced acute respiratory distress, mite powder-induced allergic asthma)
- Cytokine and chemokine expression (ELISA, multiplex, IF, cytometry)
- Gene expression by RT-qPCR (cytokines, chemokines, junction proteins, etc.)
- Analysis of cell populations (cytometry, IF)
- Histological analysis
- Development of customized tests or models for your specific needs
A team of experts
The inflammatory response studied
INFLAMMATION
TransBIOTech uses proven in vitro and in vivo models to generate proof-of-concept and data to identify the anti-inflammatory potential of your compounds.
CONTACT US
Your R&D projects require distinctive expertise that cannot be improvised. TransBIOTech provides you with complete and proven know-how with +150 projects per year, with +50 clients and partners.